Correlation between Her2/neu over-expression or gene amplification with patients’ clinico-pathological parameters and the significance of Her2/neu as a prognostic biomarker in bladder cancer will be investigated. This evidence concerns the gene ERBB2 and urinary bladder carcinoma.